Abel Hall LLC Purchases New Position in HealthEquity, Inc. $HQY

Abel Hall LLC purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 2nd quarter, Holdings Channel reports. The fund purchased 1,939 shares of the company’s stock, valued at approximately $203,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. Invesco Ltd. lifted its holdings in HealthEquity by 50.6% during the 1st quarter. Invesco Ltd. now owns 2,446,198 shares of the company’s stock valued at $216,171,000 after purchasing an additional 821,425 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in HealthEquity by 1.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,133,166 shares of the company’s stock valued at $100,138,000 after purchasing an additional 15,458 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in HealthEquity by 1.3% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,100,970 shares of the company’s stock valued at $97,293,000 after purchasing an additional 14,159 shares during the last quarter. Stephens Investment Management Group LLC lifted its holdings in HealthEquity by 1.8% during the 1st quarter. Stephens Investment Management Group LLC now owns 1,069,446 shares of the company’s stock valued at $94,507,000 after purchasing an additional 19,009 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in HealthEquity by 24.9% during the 1st quarter. Wellington Management Group LLP now owns 848,940 shares of the company’s stock valued at $75,021,000 after purchasing an additional 169,337 shares during the last quarter. 99.55% of the stock is owned by institutional investors.

HealthEquity Trading Up 4.1%

HQY opened at $92.09 on Thursday. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a market cap of $7.93 billion, a price-to-earnings ratio of 55.81, a price-to-earnings-growth ratio of 1.27 and a beta of 0.47. The firm has a 50 day simple moving average of $91.71 and a 200 day simple moving average of $93.82. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on HQY shares. KeyCorp cut their price target on shares of HealthEquity from $125.00 to $120.00 and set an “overweight” rating for the company in a report on Wednesday. Jefferies Financial Group upped their target price on shares of HealthEquity from $130.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. Royal Bank Of Canada upped their target price on shares of HealthEquity from $109.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, September 3rd. Raymond James Financial reiterated a “strong-buy” rating and set a $120.00 target price (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. Finally, JPMorgan Chase & Co. upped their target price on shares of HealthEquity from $125.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 3rd. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $121.31.

Insider Buying and Selling

In related news, EVP Michael Henry Fiore sold 1,781 shares of the business’s stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total transaction of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Delano Ladd sold 6,000 shares of the business’s stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the sale, the executive vice president directly owned 79,456 shares of the company’s stock, valued at approximately $7,477,604.16. This trade represents a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.50% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.